Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1316.00
13.00
(1.00%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr Reddys lab reports 25% rise in its Q1 net profit
>>
Dr Reddy’s Laboratories gets USFDA approval for Fondaparinux Sodium Injection
>>
Dr Reddy’s launches Amlodipine Besylate and Benazepril Hydrochloride capsules
>>
USFDA bans Dr Reddy's Mexico plant’s drugs
>>
Dr Reddy's Mexican arm receives USFDA warning letter
>>
Dr Reddy’s Mexico facility gets USFDA warning letter
>>
Dr Reddy’s Lab launches three products in the US market
>>
Dr Reddy's polypill halves heart disease and stroke risk in trial
>>
Dr Reddy's launches Fexofenadine HCl in US
>>
DRL's unit in pact with Valeant Pharma
<<
<
141
142
143
...145
>
>>